Targeting Gatekeeper Mutations for Kinase Drug Discovery-Reference-Cited by-同舟云学术

Targeting Gatekeeper Mutations for Kinase Drug Discovery

Published:2022-11-17 Issue:23 Volume:65 Page:15540-15558
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhou Yang¹^ORCID,Xiang Shuang¹,Yang Fang¹,Lu Xiaoyun¹^ORCID

Affiliation:

1. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, 855 Xingye Avenue, Guangzhou 510632, China

Funder

State Key Laboratory of Respiratory Disease

Jinan University

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

State Key Laboratory of Esophageal Cancer Prevention and Treatment

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01361

Reference122 articles.

1. The Protein Kinase Complement of the Human Genome

2. Post-translational modifications in signal integration

3. Trends in kinase drug discovery: targets, indications and inhibitor design

4. Kinase drug discovery 20 years after imatinib: progress and future directions

5. Understanding and targeting resistance mechanisms in NSCLC

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting;European Journal of Medicinal Chemistry;2024-10

2. Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs;ChemBioChem;2024-09-12

3. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

4. Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor;European Journal of Medicinal Chemistry;2024-09

5. Discovery and characterization of novel FGFR1 inhibitors in triple-negative breast cancer via hybrid virtual screening and molecular dynamics simulations;Bioorganic Chemistry;2024-09